BioWorld

Dec. 7, 2015

FDA advisory committees on the decline, results vary

It's been three years since the FDA Safety and Innovation Act, the most recent reauthorization of the user fee program, was enacted, providing plenty of data on advisory committee meetings to examine. Read More

Week in review

Word on the street

Week in Washington

Public financing of biotechnology companies: Commenced trading in November 2015

Biotech money raised by month in 2015

Public financing of biotechnology companies: Filed and pending IPOs

2015 top private financings of public companies

Other financings of public biotechnology companies: November 2015

2015 top financings of private companies

Venture capital & other investments in private biotechnology companies: November 2015

Milestone payments from corporate partners: November 2015

Money raised by biotech in 2015 vs. 2014

Money raised by biotech: Jan. 1 - Dec. 3, 2015

Nasdaq Stock Index 2015

The week's biggest gainers and losers

BioWorld Stock Index 2015

BioWorld stock report for public biotechnology companies

Today's news in brief

BioWorld

BioWorld briefs for Feb. 4, 2025.

Today's news in brief

Briefs

BioWorld MedTech briefs for Jan. 30, 2026.

MicroRNAs in circulating extracellular vesicles as IPF biomarkers

BioWorld Science

MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...

MJFF grant supports Bexorg’s translational biomarker work

BioWorld Science

Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...

REST emerges as biomarker in ALS, knockdown improves ALS symptoms

BioWorld Science

About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...